Browse Arkansas Code titles and sections

42 U.S.C. § 283q — Eureka prize competitions

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 283q — Eureka prize competitions

**(a) In general** Pursuant to the authorities and processes established under [section 3719 of title 15](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section3719&num=0&edition=prelim), the Director of the National Institutes of Health shall support prize competitions for one or both of the following goals: (1) Identifying and funding areas of biomedical science that could realize significant advancements through a prize competition. (2) Improving health outcomes, particularly with respect to human diseases and conditions— (A) for which public and private investment in research is disproportionately small relative to Federal Government expenditures on prevention and treatment activities with respect to such diseases and conditions, such that Federal expenditures on health programs would be reduced; (B) that are serious and represent a significant disease burden in the United States; or (C) for which there is potential for significant return on investment to the United States. **(b) Tracking; reporting** The Director of the National Institutes of Health shall— (1) collect information on— (A) the effect of innovations funded through the prize competitions under this section in advancing biomedical science or improving health outcomes pursuant to subsection (a); and (B) the effect of the innovations on Federal expenditures; and (2) include the information collected under paragraph (1) in the triennial report under [section 283 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section283&num=0&edition=prelim) (as amended by section 2032).

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 283q

Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: 575394069595cd9a3188e8201de9edc84810758442a4c14395455150a1124ddc. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:record_usc_1cd506d16ad21a2e9acba0f3
Source file: Laws/federal/codes/united-states-code/title-42/section-283q-eureka-prize-competitions--790503f26a.md
Pages: Not recorded – Not recorded
Passage SHA-256: 55a5a1642eb928ab8892a4784c4d2b5b85be4782a630e8ee01b8c436f7665bb9

Source location: Title 42, Chapter 6A, § 283q; chapter-6a-public-health-service.md

Stored source content

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

15 U.S.C. § 3719 — Prize competitions

**(a) Definitions** In this section: (1) **Agency** — The term “agency” means a Federal agency. (2) **Director** — The term “Director” means the Director of the Office of Science and Technology Policy. (3) **Federal agency** — The term “Federal agency” has the meaning given under [section 3703 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section3703&num=0&edition=prelim), except that term shall not include any agency of the legislative branch of the Federal Government. (4) **Head of an agency** — The term “head of an agency” means the head of a Federal agency. **(b) In general** Each head of an agency, or the heads of multiple agencies in cooperation, may carry out a program to award prizes competitively to stimulate innovation that has the potential to advance the mission of the respective agency. **(c) Prize competitions** For purposes of this section, a prize competition may be 1 or more of the following types of activities: (1) A point solution prize that rewards and spurs the development of solutions for a particular, well-defined problem. (2) An exposition prize competition that helps identify and promote a broad range of ideas and practices that may not otherwise attract attention, facilitating further development of the idea or practice by third parties. (3) Participation prize competitions that create value during and after the competition by encouraging contestants to change their behavior or develop new skills that may have beneficial effects during and after the competition. (4) Such other types of prize competitions as each head of an agency considers appropriate to stimulate innovation that has the potential to advance the mission of the respective agency. **(d) Topics** In selecting topics for prize compet

Source: Supplied U.S. Code snapshot — release unconfirmed · 15 U.S.C. § 3719

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 283 — Triennial reports of Director of NIH

**(a) In general** The Director of NIH shall submit to the Congress on a triennial basis a report in accordance with this section. The first report shall be submitted not later than 1 year after January 15, 2007. Each such report shall include the following information: (1) An assessment of the state of biomedical and behavioral research. (2) A description of the activities conducted or supported by the agencies of the National Institutes of Health and policies respecting the programs of such agencies. (3) A description of intra-National Institutes of Health activities, including— (A) identification of the percentage of funds made available by each national research institute and national center with respect to each applicable fiscal year for conducting or supporting research that involves collaboration between the institute or center and 1 or more other national research institutes or national centers; and (B) recommendations for promoting coordination of information among the centers of excellence. (4) A catalog of all the research activities of the agencies, prepared in accordance with the following: (A) The catalog shall, for each such activity— (i) identify the agency or agencies involved; (ii) state whether the activity was carried out directly by the agencies or was supported by the agencies and describe to what extent the agency was involved; and (iii) identify whether the activity was carried out through a center of excellence. (B) In the case of clinical research, the catalog shall, as appropriate, identify study populations by demographic variables, including biological and social variables and relevant age categories (such as pediatric subgroups), and determinants of health, that contribute to research on minority health and he

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 283

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 283q — Eureka prize competitions

Page 669 TITLE 42—THE PUBLIC HEALTH AND WELFARE § 283q (5) the extent to which the specified instru- ment will be shared and the benefit of the pro- posed instrument to the overall research com- munity to be served. (b) Peer review In awarding grants under the program de- scribed in subsection (a), the Director of NIH, acting through the Office of the Director of NIH, shall comply with the peer review requirements in section 289a of this title. (July 1, 1944, ch. 373, title IV, § 404L, formerly Pub. L. 106–505, title III, § 305, Nov. 13, 2000, 114 Stat. 2335; renumbered July 1, 1944, ch. 373, title IV, § 404L, and amended Pub. L. 112–74, div. F, title II, § 221(b)(4), Dec. 23, 2011, 125 Stat. 1088.) Editorial Notes CODIFICATION Section was formerly set out as a note under section 287 of this title, prior to renumbering by Pub. L. 112–74. AMENDMENTS 2011—Pub. L. 112–74, § 221(b)(4)(B)(iii), substituted ‘‘Di- rector of NIH, acting through the Office of the Director of NIH,’’ for ‘‘Director of the National Center for Re- search Resources’’ in subsecs. (a) and (b). Subsec. (a). Pub. L. 112–74, § 221(b)(4)(B)(ii), sub- stituted ‘‘under the Shared Instrumentation Grant Pro- gram’’ for ‘‘under the program described in subsection (a)’’ in introductory provisions. Pub. L. 112–74, § 221(b)(4)(B)(i), redesignated subsec. (b) as (a) and struck out former subsec. (a). Prior to amendment, text of subsec. (a) read as follows: ‘‘There is authorized to be appropriated $100,000,000 for fiscal year 2000, and such sums as may be necessary for each subsequent fiscal year, to enable the Secretary of Health and Human Services, acting through the Direc- tor of the National Center for Research Resources, to provide for the continued operation of the Shared In- strumen

Source: Supplied 2024 U.S. Code historical extraction · 42 U.S.C. § 283q

Stored review status: historical_2024_not_currentness_verified. Same stored citation; legal effect and authority still require review.